Latest Insider Transactions at Oak Street Health, Inc. (OSH)
This section provides a real-time view of insider transactions for Oak Street Health, Inc. (OSH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oak Street Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oak Street Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
45,794
-3.42%
|
$1,373,820
$30.12 P/Share
|
|
Aug 04
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
53,366
-3.83%
|
$1,600,980
$30.01 P/Share
|
|
Aug 03
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,176
-0.04%
|
$95,280
$30.3 P/Share
|
|
Aug 03
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
2,600
-0.19%
|
$78,000
$30.24 P/Share
|
|
Aug 02
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
157,534
-2.14%
|
$4,726,020
$30.03 P/Share
|
|
Aug 02
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
147,511
-9.56%
|
$4,425,330
$30.03 P/Share
|
|
Aug 02
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
40,000
-6.28%
|
$1,200,000
$30.0 P/Share
|
|
Jul 28
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
200,000
-1.91%
|
$5,600,000
$28.77 P/Share
|
|
Jul 28
2022
|
Geoffrey M Price Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+0.09%
|
-
|
|
Jul 26
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-2.53%
|
$1,080,000
$27.97 P/Share
|
|
Jul 20
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
150,000
-8.65%
|
$3,150,000
$21.2 P/Share
|
|
Jul 12
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
62,800
-1.75%
|
$1,381,600
$22.67 P/Share
|
|
Jun 29
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
632
-0.04%
|
$11,376
$18.0 P/Share
|
|
Jun 28
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
96,568
-1.71%
|
$1,834,792
$19.3 P/Share
|
|
May 31
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
120,000
-5.96%
|
$2,160,000
$18.91 P/Share
|
|
May 03
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
60,000
-1.45%
|
$1,140,000
$19.1 P/Share
|
|
Apr 27
2022
|
Cheryl Dorsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,373
+29.88%
|
-
|
|
Apr 27
2022
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,373
+4.71%
|
-
|
|
Apr 27
2022
|
Kim Keck Director |
SELL
Grant, award, or other acquisition
|
Direct |
10,373
-13.06%
|
-
|
|
Apr 27
2022
|
Julie D Klapstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,373
+27.96%
|
-
|
|
Apr 27
2022
|
Paul B. K. Kusserow Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,373
+2.14%
|
-
|
|
Apr 27
2022
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,373
+35.64%
|
-
|
|
Apr 19
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
60,000
-1.41%
|
$1,500,000
$25.18 P/Share
|
|
Apr 05
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
60,000
-1.37%
|
$1,560,000
$26.92 P/Share
|
|
Mar 22
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
80,000
-1.18%
|
$1,920,000
$24.68 P/Share
|
|
Mar 03
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.15%
|
$315,000
$21.54 P/Share
|
|
Feb 21
2022
|
Timothy M Cook Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,841
+4.89%
|
-
|
|
Feb 21
2022
|
Griffin Myers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
25,396
+0.48%
|
-
|
|
Feb 21
2022
|
Robert Guenthner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+6.53%
|
-
|
|
Feb 21
2022
|
Geoffrey M Price Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,841
+1.77%
|
-
|
|
Feb 21
2022
|
Brian Clem Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,841
+9.68%
|
-
|
|
Feb 17
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.26%
|
$240,000
$16.73 P/Share
|
|
Feb 04
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,151
-0.19%
|
$18,416
$16.66 P/Share
|
|
Feb 04
2022
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,514
-0.12%
|
$24,224
$16.66 P/Share
|
|
Feb 04
2022
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
606
-0.14%
|
$9,696
$16.66 P/Share
|
|
Jan 11
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
12,500
-0.55%
|
$312,500
$25.02 P/Share
|
|
Jan 04
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-0.11%
|
$825,000
$33.66 P/Share
|
|
Dec 31
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Grant, award, or other acquisition
|
Direct |
417
-0.01%
|
$11,676
$28.17 P/Share
|
|
Dec 28
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.59%
|
$935,000
$34.49 P/Share
|
|
Dec 21
2021
|
Michael T Pykosz Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,761
+0.06%
|
$99,981
$21.0 P/Share
|
|
Dec 17
2021
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,716
+0.12%
|
$99,036
$21.0 P/Share
|
|
Dec 16
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,533
-0.28%
|
$78,523
$31.92 P/Share
|
|
Dec 14
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.59%
|
$880,000
$32.24 P/Share
|
|
Dec 08
2021
|
Griffin Myers Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
8,500
-0.18%
|
-
|
|
Dec 08
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
20,000
-4.28%
|
-
|
|
Dec 07
2021
|
Robert Guenthner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.07%
|
$210,000
$21.0 P/Share
|
|
Dec 02
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
419
-0.09%
|
$12,989
$31.44 P/Share
|
|
Nov 23
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.29%
|
$852,500
$31.87 P/Share
|
|
Nov 18
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,476
-0.16%
|
$54,612
$37.13 P/Share
|
|
Nov 16
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.34%
|
$2,000,000
$40.01 P/Share
|